Beeline Medicines reports promising Phase 2 lupus data

The business of advancing shelved pharma assets continues to reap benefits, this time for Beeline Medicines and a lupus candidate provided by Bristol Myers Squibb. The buzzy Bain-backed startup said Wednesday that its drug afimetoran ...